JP Morgan Chase
AURA icon

JP Morgan Chase’s Aura Biosciences AURA Stock Holding History

JP Morgan Chase’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$146K Buy
23,535
+416
+2% +$2.39K ﹤0.01% 5637
2025
Q4 		$126K Sell
23,119
-1,438
-6% -$8.54K ﹤0.01% 5765
2025
Q3 		$152K Buy
24,557
+2,693
+12% +$17.6K ﹤0.01% 5667
2025
Q2 		$137K Sell
21,864
-4,259
-16% -$24.9K ﹤0.01% 5453
2025
Q1 		$153K Sell
26,123
-68,263
-72% -$516K ﹤0.01% 5366
2024
Q4 		$776K Buy
94,386
+40,884
+76% +$385K ﹤0.01% 4794
2024
Q3 		$477K Buy
53,502
+27,718
+108% +$238K ﹤0.01% 4922
2024
Q2 		$195K Buy
25,784
+1,499
+6% +$11K ﹤0.01% 5176
2024
Q1 		$191K Buy
24,285
+5,925
+32% +$49.1K ﹤0.01% 5381
2023
Q4 		$163K Sell
18,360
-281
-2% -$2.38K ﹤0.01% 5498
2023
Q3 		$167K Sell
18,641
-3,030
-14% -$32.6K ﹤0.01% 5176
2023
Q2 		$268K Buy
21,671
+3,173
+17% +$33.9K ﹤0.01% 4896
2023
Q1 		$171K Buy
18,498
+7,752
+72% +$80.5K ﹤0.01% 5148
2022
Q4 		$113K Buy
10,746
+733
+7% +$9.33K ﹤0.01% 5306
2022
Q3 		$181K Buy
10,013
+215
+2% +$3.25K ﹤0.01% 5005
2022
Q2 		$139K Buy
9,798
+7,170
+273% +$119K ﹤0.01% 5246
2022
Q1 		$58K Sell
2,628
-3,967
-60% -$75.6K ﹤0.01% 5735
2021
Q4 		$112K Buy
+6,595
New +$118K ﹤0.01% 5621

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase's AURA Position: Q1 2026 in Review

JP Morgan Chase increased its Aura Biosciences (AURA) stake by 1.8% in Q1 2026, buying an estimated $2.39K and bringing the position to 23,535 shares worth $146K. The position accounts for ﹤0.01% of the portfolio, ranked #5637.

JP Morgan Chase first reported a position in AURA in Q4 2021 and has held it in 18 quarters since. The position peaked at $776K in Q4 2024. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • JP Morgan Chase held 23,535 shares of Aura Biosciences worth $146K as of Q1 2026.
  • JP Morgan Chase bought 416 Aura Biosciences shares in Q1 2026, an estimated $2.39K.
  • Aura Biosciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #5637 holding.
  • JP Morgan Chase first reported a position in Aura Biosciences in Q4 2021 and has held it in 18 quarters since.
  • JP Morgan Chase's Aura Biosciences position peaked at $776K in Q4 2024.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.